Popular Articles

Costliest Medicare Markets In Florida, New York, California
U.S. News & World Report examines cost, frequency, and outcomes studies on Medicare patients from the Dartmouth Institute for Health Policy and Clinical Practice : "The Dartmouth research is particularly relevant to older Americans because it is based to a large extent on Medicare data, involving patients ages 65 and older. The 2008 atlas, in particular, paints a devastating portrait of Medicare treatments based on an extensive study of Medicare recipients who died from one or more of nine chronic illnesses. Not only are chronic illnesses very expensive to treat, but they"re also the cause of most deaths in the United States. According to the 2008 atlas: More than 90 million Americans live with at least one chronic illness, and 7 out of 10 Americans die from chronic disease. Among the population that receives Medicare, the toll is even greater: About 9 out of 10 deaths are associated with just nine chronic illnesses: congestive heart failure, chronic lung disease, cancer, coronary artery disease, renal failure, peripheral vascular disease, diabetes, chronic liver disease, and dementia."
drugs without prescription
Innovative Technology Shatters The Barriers Of Modern Light Microscopy
Researchers at the Helmholtz Zentrum MÃønchen and the Technische Universität MÃønchen are using a combination of light and ultrasound to visualize fluorescent proteins that are seated several centimeters deep into living tissue. In the past, even modern technologies have failed to produce high-resolution fluorescence images from this depth because of the strong scattering of light. In the Nature Photonics journal, the Munich researchers describe how they can reveal genetic expression within live fly larvae and fish by "listening to light". In the future this technology may facilitate the examination of tumors or coronary vessels in humans.
News of the day
"Bicycling For Ovarian Cancer" Around Perimeter Of United States Begins Today
A 9,000-mile trek in 100 hundred days around the perimeter of United States to raise money to cure ovarian cancer begins today. The cyclist, Craig Broeder, Ph.D., is an exercise physiologist and Fellow of the American College of Sports Medicine (ACSM) who is dedicating his ride to help fund research and build awareness about ovarian cancer.
Oncology

Screening For Left Ventricular Dysfunction May Have Less Value Than Thought

The value and cost-effectiveness of screening for left ventricular (LV) dysfunction remains unclear, particularly since specific, evidence-based treatments are not available for the majority of patients with preserved systolic dysfunction, reports a study in the June issue of the Journal of Cardiac Failure, published by Elsevier. In the study,1012 primary care patients with hypertension and/or diabetes without signs or symptoms of heart failure were screened for asymptomatic left ventricular dysfunction (ALVD), using measurements of NT-pro-BNP and echocardiography. Diastolic dysfunction was found in 368 subjects (36%) and was categorized as mild in 327 and moderate-severe in 41. Systolic dysfunction was present in only 11 (1.1%)l. NT-proBNP levels were 170÷±206 and 859÷±661 pg/mL respectively in diastolic and systolic dysfunction and 92÷±169 in normal subjects (p99% and a positive predictive value of 33% in patients Journal of Cardiac Failure. Notes: The full study is "The Role of N-Terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure: The PROBE-HF Study" by Irene Betti, Gabriele Castelli, Alessandro Barchielli, Cinzia Beligni, Vittorio Boscherini, Leonardo De Luca, Gianni Messeri, Mihai Gheorghiade, Alan Maisel, and Alfredo Zuppiroli. Journal of Cardiac Failure. Volume 15, Issue 5, June 2009, Pages 377-384. Maureen Hunter Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):